Grantia

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

Research grant focused on integrating climate-related exposures into the human exposome to characterize its health impacts under climate change. Targets multidisciplinary consortia of researchers, policymakers, and healthcare practitioners advancing exposome science with climate data.

Details

Agency

EU Commission

Status

Open

Language

English

Funding Type

Grant

Funding Amount

Up to 11.0M €

Deadline

2027-04-13

Open Date

2027-02-10

Overview

Research grant focused on integrating climate-related exposures into the human exposome to characterize its health impacts under climate change. Targets multidisciplinary consortia of researchers, policymakers, and healthcare practitioners advancing exposome science with climate data.

Who Can Apply

Consortia of legal entities (e.g., universities, research institutions, public bodies, private organizations) from eligible countries. Participation of social sciences and humanities (SSH) experts is mandatory. US-based entities are eligible for EU funding under specific conditions.

Funding Details

Maximum grant amount: 11,000,000 EUR. Co-funding requirements or funding rates are not specified.

What Is Funded

  • Integration of climate-related exposures (e.g., extreme heat, air pollution) into exposome research.
  • Multidisciplinary studies on exposome changes due to climate pressures and their health implications.
  • Development of AI/machine learning methodologies for exposome data analysis, including Real-World Data (RWD).
  • Longitudinal cohort studies combining exposome, medical, omics, and biological data.
  • Identification of exposome indicators, biomarkers, and intersectional vulnerability factors (e.g., socioeconomic, demographic).
  • Expansion of exposome toolboxes to include climate-related exposures.
  • Dissemination of findings to policymakers, healthcare practitioners, and the public.

Technology / Maturity Requirements

Projects must operate at Technology Readiness Levels (TRL) 4–6.

Key Dates

  • Open date: 2027-02-09
  • Deadline: 2027-04-12T22:00:00Z

Application Process (High-Level)

Single-stage application process. Proposals must be submitted via the Funding & Tenders Portal. Clinical studies, if included, require a dedicated annex.

Post-Award Obligations

  • Participation in a cluster of funded projects for joint networking, dissemination, and reporting activities (allocating ~2% of the budget).
  • Sharing of chemical and human biomonitoring data in the Common Data Platform for Chemicals (IPCHEM).
  • Uploading tools to the IHEN Exposome Toolbox and datasets to the IHEN Data Catalogue.
  • Reporting findings to the European Climate and Health Observatory.
  • Compliance with FAIR data principles and potential transfer-of-ownership restrictions for up to 4 years post-project.

Geographic Scope & Language

Eligible countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Norway, Iceland, United Kingdom, Switzerland. Application language: English.

Notes

  • Mandatory inclusion of SSH disciplines.
  • Encouraged international cooperation, particularly with underrepresented regions in exposome research.
  • Proposals must leverage existing initiatives (e.g., EHEN, IHEN, ICOS ERIC, EIRENE RI) and European research infrastructures.
  • Projects must account for sex-, gender-, and racial/ethnic-disaggregated data where relevant.